Volume 43, Issue 48, 21 December 2022

Issue @ A Glance

Focus on trials: dementia, lipids, thrombosis, and heart failure

Filippo Crea

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 4965–4969, https://doi.org/10.1093/eurheartj/ehac746

• Extract
• View article

CardioPulse

Future technologies in total artificial heart development: can a robot become as good as a donor heart?

Maziar Arfaee and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 4970–4972, https://doi.org/10.1093/eurheartj/ehac512

• Extract
• View article

Heart Failure Association/European Society of Cardiology Atlas second edition: new insights into understanding the burden of heart failure

Petar M Seferović and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 4973–4975, https://doi.org/10.1093/eurheartj/ehac513

• Extract
• View article
• Supplementary data

Long QT syndrome: long story short

Jin Li

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 4976–4977, https://doi.org/10.1093/eurheartj/ehac551

• Extract
• View article

CardioPulse

Weekly Journal Scan

Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR

Rocco Vergallo and Massimo Volpe

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 4978–4979, https://doi.org/10.1093/eurheartj/ehac595

• Extract
• View article

Fast Track Clinical Research

Editor's Choice

Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis

Ruth Peters and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 4980–4990, https://doi.org/10.1093/eurheartj/ehac584

• Abstracts
• View article
• Supplementary data

Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme

Faiez Zannad and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 4991–5002, https://doi.org/10.1093/eurheartj/ehac495

• Abstracts
• View article
• Supplementary data

Editorial

SGLT2 inhibitors in heart failure: insights from plasma proteomics

Clemens Gutmann and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5003–5005, https://doi.org/10.1093/eurheartj/ehac624

• Abstract
• View article

Fast Track Clinical Research

Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial

Marco Metra and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5006–5016, https://doi.org/10.1093/eurheartj/ehac293

• Abstracts
• View article
• Supplementary data

Editorial

Omecamtiv mecarbil for patients with severe systolic dysfunction and hypotension

Maria Generosa Crespo-Leiro and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5017–5019, https://doi.org/10.1093/eurheartj/ehac552

• Abstract
• View article

Fast Track Clinical Research

Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry

Joel P Giblett and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5020–5032, https://doi.org/10.1093/eurheartj/ehac511

• Abstracts
• View article
• Supplementary data

Editorial

Management of post-infarction ventricular septal defects: are we moving forward?

Fernando Alfonso and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5033–5036, https://doi.org/10.1093/eurheartj/ehac532

• Abstract
• View article

Clinical Research

Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54

Marc P Bonaca and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5037–5044, https://doi.org/10.1093/eurheartj/ehac402

• Abstracts
• View article
• Supplementary data

Editorial

Platelet antiaggregation after an acute coronary syndrome: what about the elderly?

Kurt Huber

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5045–5046, https://doi.org/10.1093/eurheartj/ehac405

• Abstract
• View article

Clinical Research

Effect of inclisiran on lipids in primary prevention: the ORION-11 trial

Kausik K Ray and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5047–5057, https://doi.org/10.1093/eurheartj/ehac615

• Abstracts
• View article
• Supplementary data

Editorial

Inclisiran in primary prevention: reality or fiction?

Baris Gencer and François Mach

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5058–5060, https://doi.org/10.1093/eurheartj/ehac653

• Abstract
• View article

Discussion Forum

dal-GenE was negative—not positive except for COVID-19

Allan D Sniderman

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Page 5061, https://doi.org/10.1093/eurheartj/ehac637

• Extract
• View article

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome

Jean-Claude Tardif and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5062–5063, https://doi.org/10.1093/eurheartj/ehac644

• Extract
• View article

Cardiovascular Flashlight

Unexpected find of native aortic leaflet thrombus during surgical myocardial revascularization

Erwan Salaun and others

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Page 5064, https://doi.org/10.1093/eurheartj/ehac589

• Extract
• View article

Growing giant coronary artery aneurysm

Daisuke Fukamachi and Yasuo Okumura

European Heart Journal, Volume 43, Issue 48, 21 December 2022, Page 5065, https://doi.org/10.1093/eurheartj/ehac639

• Extract
• View article